Citadel Advisors’s 908 Devices MASS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,600
Closed -$119K 13503
2025
Q3
$119K Buy
+13,600
New +$90.4K ﹤0.01% 11718
2025
Q2
Sell
-10,900
Closed -$48.8K 14010
2025
Q1
$48.8K Buy
10,900
+7,500
+221% +$22.2K ﹤0.01% 12334
2024
Q4
$7.48K Sell
3,400
-18,600
-85% -$53.3K ﹤0.01% 13736
2024
Q3
$76.3K Buy
22,000
+20,600
+1,471% +$91.4K ﹤0.01% 11465
2024
Q2
$7.21K Sell
1,400
-1,300
-48% -$7.85K ﹤0.01% 13267
2024
Q1
$20.4K Buy
2,700
+1,800
+200% +$13.3K ﹤0.01% 13003
2023
Q4
$10.1K Buy
+900
New +$6.15K ﹤0.01% 13119
2023
Q3
Sell
-3,500
Closed -$24K 14761
2023
Q2
$24K Sell
3,500
-400
-10% -$3.22K ﹤0.01% 12570
2023
Q1
$33.5K Sell
3,900
-1,300
-25% -$11.6K ﹤0.01% 12622
2022
Q4
$39.6K Buy
+5,200
New +$62.9K ﹤0.01% 12431
2022
Q1
Sell
-10,400
Closed -$269K 14182
2021
Q4
$269K Buy
+10,400
New +$306K ﹤0.01% 11159

Other funds holding MASS

Citadel Advisors's MASS Position: Q1 2026 in Review

Citadel Advisors reduced its 908 Devices (MASS) stake by 45% in Q1 2026, selling an estimated $751K and leaving 144,547 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #7947.

Citadel Advisors first reported a position in MASS in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.39M in Q4 2025. 112 funds tracked by Wall St. Rank hold MASS as of Q1 2026.

  • Citadel Advisors held 144,547 shares of 908 Devices worth $885K as of Q1 2026.
  • Citadel Advisors sold 119,826 908 Devices shares in Q1 2026, an estimated $751K.
  • 908 Devices made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7947 holding.
  • Citadel Advisors first reported a position in 908 Devices in Q4 2021 and has held it in 13 quarters since.
  • Citadel Advisors's 908 Devices position peaked at $1.39M in Q4 2025.
  • 112 funds tracked by Wall St. Rank held 908 Devices as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.